TW200403059A - Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd - Google Patents
Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd Download PDFInfo
- Publication number
- TW200403059A TW200403059A TW092116257A TW92116257A TW200403059A TW 200403059 A TW200403059 A TW 200403059A TW 092116257 A TW092116257 A TW 092116257A TW 92116257 A TW92116257 A TW 92116257A TW 200403059 A TW200403059 A TW 200403059A
- Authority
- TW
- Taiwan
- Prior art keywords
- alkyl
- represents hydrogen
- formula
- halogen
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/02—Sulfinic acids; Derivatives thereof
- C07C313/04—Sulfinic acids; Esters thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201940A SE0201940D0 (sv) | 2002-06-20 | 2002-06-20 | New combination II |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200403059A true TW200403059A (en) | 2004-03-01 |
Family
ID=20288298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW092116257A TW200403059A (en) | 2002-06-20 | 2003-06-16 | Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR040203A1 (sv) |
AU (1) | AU2003237739A1 (sv) |
SE (1) | SE0201940D0 (sv) |
TW (1) | TW200403059A (sv) |
WO (1) | WO2004000856A1 (sv) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ547204A (en) | 2000-05-26 | 2008-01-31 | Idenix Cayman Ltd | Methods and compositions for treating flaviviruses and pestiviruses |
AU2004243444A1 (en) * | 2003-05-27 | 2004-12-09 | Altana Pharma Ag | Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |
WO2005077345A1 (en) * | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Compounds for the treatment of gastro-esophageal reflux disease |
SE0402462D0 (sv) * | 2004-10-08 | 2004-10-08 | Astrazeneca Ab | New process |
US7566738B2 (en) | 2004-11-03 | 2009-07-28 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use |
US7494985B2 (en) | 2004-11-03 | 2009-02-24 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use |
GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
WO2008033572A1 (en) | 2006-09-15 | 2008-03-20 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
EP2531510B1 (en) | 2010-02-01 | 2014-07-23 | Novartis AG | Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
WO2011095450A1 (en) | 2010-02-02 | 2011-08-11 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
AR086554A1 (es) | 2011-05-27 | 2014-01-08 | Novartis Ag | Derivados de la piperidina 3-espirociclica como agonistas de receptores de la ghrelina |
MA20150428A1 (fr) | 2012-05-03 | 2015-11-30 | Novartis Ag | Sel de l-malate de dérivés de 2,7-diaza-spiro[4.5]déc-7-yle et ses formes cristallines à titre d'agonistes des récepteurs de ghreline |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
SE9801526D0 (sv) * | 1998-04-29 | 1998-04-29 | Astra Ab | New compounds |
SE9904507D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
SE9904508D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
-
2002
- 2002-06-20 SE SE0201940A patent/SE0201940D0/sv unknown
-
2003
- 2003-06-11 AR ARP030102095A patent/AR040203A1/es not_active Application Discontinuation
- 2003-06-16 TW TW092116257A patent/TW200403059A/zh unknown
- 2003-06-16 AU AU2003237739A patent/AU2003237739A1/en not_active Abandoned
- 2003-06-16 WO PCT/SE2003/001008 patent/WO2004000856A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003237739A1 (en) | 2004-01-06 |
AR040203A1 (es) | 2005-03-16 |
SE0201940D0 (sv) | 2002-06-20 |
WO2004000856A1 (en) | 2003-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2892954T3 (es) | Derivados fluorados del ácido 3-(2-oxo-3-(3-(5,6,7,8-tetrahidro-1,8-naftiridin-2-il)propil)imidazolidin-1-il)propanoico y usos de los mismos | |
EP2458996B1 (en) | Novel oral forms of a phosphonic acid derivative | |
US20090023712A1 (en) | Pharmaceutical Compositions for the Treatment of Attention Deficit Hyperactivity Disorder Comprising Flibanserin | |
TW200403059A (en) | Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd | |
CN110317192A (zh) | 一类具有降解雄激素受体活性的化合物 | |
JP2003523410A (ja) | 治療薬 | |
JP2021527031A (ja) | セピアプテリンの薬学的に許容される塩 | |
WO2016155545A1 (zh) | 含氨磺酰基的1,2,5-噁二唑类衍生物、其制备方法及其在医药上的应用 | |
WO2013081154A1 (ja) | キナーゼ阻害剤の副作用低減剤 | |
ES2672468T3 (es) | Momelotinib deuterado | |
JP2014504258A (ja) | 選択的プロトン共役葉酸輸送体および葉酸受容体ならびにGARFTaseおよび/または他の葉酸代謝酵素のインヒビター化合物、ならびにその使用方法 | |
CN105246483A (zh) | 用于γ-谷氨酰循环调节的方法和组合物 | |
TWI287986B (en) | Use of Epothilones for the treatment of the carcinoid syndrome | |
KR20040106422A (ko) | 간암 및 다른 암 질병 치료용 에포틸론 유도체 | |
JP5100619B2 (ja) | ロキソプロフェン含有医薬製剤1 | |
JP2024504424A (ja) | 哺乳動物における体重減少を引き起こすための外因性ケトンエステルの使用 | |
WO2004000855A1 (en) | Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd | |
CN109963853A (zh) | 一类具有降解酪氨酸蛋白激酶jak3活性的化合物 | |
JP2002293745A (ja) | 慢性関節リウマチ治療剤 | |
CN109879840B (zh) | 4-哌嗪甲基-7-羟基苯并呋喃类化合物及其医药用途 | |
JPH10212235A (ja) | 抗腫瘍剤 | |
ES2672326T3 (es) | Analogos de tiazolidinona deuterados como agonistas para el receptor de la hormona folículo estimulante | |
WO2025113523A1 (zh) | 熊果酸和多靶点酪氨酸激酶受体抑制剂的药物组合 | |
CA3203125A1 (en) | Endoxifen for treatment of ovarian cancer | |
CN116731305A (zh) | 一种抗肿瘤大环内酯聚合物及其制备方法和应用 |